We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+1.78%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.34B
AUM Growth
–
Cap. Flow
+$4.36B
Cap. Flow
% of AUM
81.59%
Top 10 Holdings %
Top 10 Hldgs %
16.76%
Holding
517
New
456
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0
quarters
Top 10 Avg Time Held Equity + Options
0
quarters
Top 20 Avg Time Held Equity + Options
0
quarters
Avg Time Held Equity only
0
quarters
Top 10 Avg Time Held Equity only
0
quarters
Top 20 Avg Time Held Equity only
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$173M |
| 2 |
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$92.2M |
| 3 |
Mondelez International
MDLZ
|
+$78.2M |
| 4 |
Estee Lauder
EL
|
+$66.3M |
| 5 |
Coca-Cola
KO
|
+$65.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.34% |
| 2 | Consumer Staples | 15.45% |
| 3 | Real Estate | 13.97% |
| 4 | Consumer Discretionary | 7.8% |
| 5 | Healthcare | 7.62% |
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for UBS O'Connor, which disclosed 517 positions worth $5.34B. Its ten largest holdings account for 17% of the portfolio.
Its largest position is Pfizer: 6,269,077 shares worth $167M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, followed by Consumer Staples and Real Estate.
- UBS O'Connor's largest Q2 2013 buy was Pfizer: 6,269,077 shares worth $167M.
- UBS O'Connor's ten largest holdings make up 17% of its $5.34B portfolio in Q2 2013.
- UBS O'Connor disclosed 517 positions in Q2 2013, its first 13F filing on record.
Based on UBS O'Connor's 13F filing for Q2 2013, filed 13 Aug 2013.